Petrylak DP, Ratta R, Matsubara N, Korbenfeld E, et al. Pembrolizumab Plus Docetaxel Versus Docetaxel for Previously Treated Metastatic Castration-Resistant Prostate Cancer: The Randomized, Double-Blind, Phase III KEYNOTE-921 Trial. J Clin Oncol 2025 Mar 5:JCO2401283. doi: 10.1200/JCO-24-01283.
PMID: 40043230